Home / Resource Library / First-Line Brutons Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell LymphomaFirst-Line Brutons Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma Article reviews first line treatment options for MCL.